Small Cell Lung Cancer
Showing NaN - NaN of 31
Small Cell Lung Cancer Trial in Worldwide (biological, drug, radiation)
Recruiting
- Small Cell Lung Cancer
- Pembrolizumab 200 mg
- +8 more
-
Chandler, Arizona
- +170 more
Feb 2, 2023
NSCLC, Small Cell Lung Cancer Trial in Worldwide (Durvalumab, Cisplatin, Carboplatin)
Active, not recruiting
- Non-Small Cell Lung Cancer
- Small Cell Lung Cancer
- Durvalumab
- +3 more
-
Houston, Texas
- +7 more
Feb 1, 2023
Clear Cell Renal Cell Cancer, Non-Small-Cell Lung Cancer, Triple Negative Breast Tumors Trial in Worldwide (AZD8701, Durvalumab)
Recruiting
- Clear Cell Renal Cell Cancer
- +8 more
- AZD8701
- Durvalumab
-
La Jolla, California
- +22 more
Aug 12, 2022
Microsatellite High Cancers, Peritoneal Mesothelioma, Extrapulmonary High Grade Trial in Houston (XmAb20717)
Recruiting
- Microsatellite High Cancers
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Aug 8, 2022
Any Advanced Solid Tumors, Triple Negative Breast Cancer, Non Small Cell Lung Cancer Trial in United States (NT-I7,
Recruiting
- Any Advanced Solid Tumors
- +6 more
-
Tampa, Florida
- +7 more
Jul 13, 2022
Small Cell Lung Cancer Trial in Worldwide (Trilaciclib, Placebo, Topotecan)
Small Cell Lung Cancer, Gastric Adenocarcinoma, Esophageal Adenocarcinoma Trial in United States (PDR001, LAG525)
Completed
- Small Cell Lung Cancer
- +7 more
- PDR001
- LAG525
-
San Francisco, California
- +19 more
May 4, 2022
Small Cell Lung Cancer Trial in Worldwide (Trilaciclib, Placebo, Carboplatin)
Terminated
- Small Cell Lung Cancer
- Trilaciclib
- +4 more
-
Beverly Hills, California
- +44 more
Apr 8, 2022
Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer Trial in United States (PF-07104091 monotherapy dose escalation,
Recruiting
- Small Cell Lung Cancer
- +4 more
- PF-07104091 monotherapy dose escalation
- +8 more
-
Clive, Iowa
- +22 more
Apr 26, 2022
NSCLC, Small Cell Lung Cancer, Urothelial Carcinoma Trial in United States (N-803 + Pembrolizumab, N-803 + Nivolumab, N-803 +
Active, not recruiting
- Non-Small Cell Lung Cancer
- +12 more
- N-803 + Pembrolizumab
- +9 more
-
Anchorage, Alaska
- +34 more
Apr 4, 2022
Metastatic Solid Tumor, Colorectal Cancer, Neuroendocrine Tumors Trial in United States (Surufatinib and Tislelizumab _ Part 1,
Recruiting
- Metastatic Solid Tumor
- +6 more
- Surufatinib and Tislelizumab _ Part 1
- Surufatinib and Tislelizumab _ Part 2
-
Tucson, Arizona
- +17 more
Apr 1, 2022
Small Cell Lung Cancer Trial in Tampa, Houston (AMG 119)
Suspended
- Small Cell Lung Cancer
- AMG 119
-
Tampa, Florida
- +1 more
Nov 29, 2021
Melanoma (Excluding Uveal Melanoma), Cervical Carcinoma, Pancreatic Carcinoma Trial in United States (XmAb®23104, Yervoy®
Recruiting
- Melanoma (Excluding Uveal Melanoma)
- +15 more
- XmAb®23104
- Yervoy® (ipilimumab)
-
San Diego, California
- +15 more
Sep 20, 2021
Small Cell Lung Cancer Trial in Worldwide (LY3295668 Erbumine)
Completed
- Small Cell Lung Cancer
- LY3295668 Erbumine
-
Fayetteville, Arkansas
- +39 more
Jul 30, 2021
Small Cell Lung Cancer Trial in Worldwide (Placebo for dexamethasone, Placebo for rovalpituzumab tesirine, Rovalpituzumab
Terminated
- Small Cell Lung Cancer
- Placebo for dexamethasone
- +3 more
-
Huntsville, Alabama
- +307 more
Jul 28, 2021
Small Cell Lung Cancer Trial in Worldwide (Veliparib, Carboplatin, Etoposide)
Small Cell Lung Cancer Trial in Worldwide (Prexasertib)
Completed
- Small Cell Lung Cancer
-
Fayetteville, Arkansas
- +40 more
Mar 12, 2020
NSCLC, Small Cell Lung Cancer, Carcinoid Trial in Houston (Proton Therapy)
Terminated
- Non-small Cell Lung Cancer
- +4 more
- Proton Therapy
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 30, 2019